In CML BP, where abundant BCR::ABL1 transcripts are generated, an increase in MAPK activation yields more hnRNP E2, ultimately causing a block in differentiation by binding to CEBPA and preventing its translation [80]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.